Paper
0
Dapagliflozin in Patients with Chronic Kidney Disease
Authors
Published
Sep 24, 2020
Show more
Save
Tip0
TipSave
Abstract
Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.